Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» cancer
cancer
Merck to acquire $1bn equity stake in Seattle Genetics; announces two oncology collaborations
Biopharma Reporter
Mon, 09/14/20 - 10:58 am
Merck
Seattle Genetics
cancer
oncology
ADCs
Tukysa
ladiratuzumab vedotin
Esmo 2020 preview – late-breaking immunotherapy
EP Vantage
Mon, 09/14/20 - 10:53 am
ESMO
immunotherapy
Big Pharma
Merck
Bristol-Meyers Squibb
cancer
Immunomedics
Roche
Gilead to buy cancer drugmaker Immunomedics for $21B
BioPharma Dive
Sun, 09/13/20 - 10:26 pm
Gilead Sciences
M&A
cancer
Immunomedics
Jazz inks Redx pact to secure 2 targeted cancer therapies
Fierce Biotech
Wed, 09/9/20 - 10:34 am
Jazz Pharmaceuticals
Redx
cancer
targeted therapies
Oncology biotech Prelude guns for $100M IPO
Fierce Biotech
Tue, 09/8/20 - 11:01 am
Prelude Therapeutics
IPOs
cancer
FDA Approves Blueprint Cancer Drug Targeting RET Genetic Signatures
Xconomy
Sun, 09/6/20 - 07:22 pm
Blueprint Medicines
FDA
Gavreto
pralsetinib
cancer
RET
non-small cell lung cancer
Triumvira Immunologics raises $55M in Series A funding round for new form of cancer cell therapy
MedCity News
Sun, 08/30/20 - 11:22 pm
Triumvira
Bayer
clinical trials
cell therapy
cancer
Foundation Medicine wins FDA OK for pan-tumor test as liquid biopsy market heats up
BioPharma Dive
Thu, 08/27/20 - 10:11 pm
Foundation Medicine
FDA
cancer
liquid biopsy
diagnostics
solid tumors
pan-cancer
The Inside Story Of Biotech’s Barnum And His Covid Cures
Forbes
Thu, 08/27/20 - 12:39 pm
Patrick Soon-Shiong
pandemic
cancer
COVID-19
NantKwest
ImmunityBio
Kinnate Raises $98M for Human Tests of Targeted Cancer Therapies
Xconomy
Wed, 08/26/20 - 11:39 pm
Kinnate Biopharma
cancer
oncology
Vir enlists Covid-19 antibody rival for cancer, infectious disease discovery work
Endpoints
Mon, 08/24/20 - 10:43 am
Vir Biotechnology
Harbor BioMed
cancer
infectious diseases
'We want to be everywhere.' Mission Bio raises $70M behind resistance-hunting sequencing platform
Endpoints
Fri, 08/14/20 - 09:45 am
Mission Bio
single cell sequencing
cancer
Achilles Heel of Immunotherapy-Resistant Cancers Revealed – and Eliminated – in Early Studies
BioSpace
Wed, 08/12/20 - 11:47 pm
cancer
oncology
immunotherapy-resistant cancer
Sanofi, GlaxoSmithKline disclose DOJ investigation into Zantac after recalls
Fierce Pharma
Tue, 08/4/20 - 12:34 pm
Sanofi
GSK
FDA
Zantac
DOJ
cancer
product recalls
False Claims Act
Eli Lilly crashes out of KRAS race as toxicity sees it ditch phase 1 effort
Fierce Biotech
Thu, 07/30/20 - 11:11 am
Eli Lilly
KRAS inhibitors
cancer
GSK’s latest pipeline review includes a slate of COPD programs headed to the scrap heap
Endpoints
Wed, 07/29/20 - 12:41 pm
GSK
R&D
COPD
HIV
cancer
Thrive Brings in $257 Million More to Advance Cancer Liquid Biopsy Assay
BioSpace
Wed, 07/29/20 - 12:28 pm
Thrive Earlier Detection
liquid biopsies
cancer
diagnostics
AstraZeneca inks $6bn cancer drug deal with Daiichi Sankyo
Pharmaforum
Mon, 07/27/20 - 11:00 am
AstraZeneca
Daiichi Sankyo
DS-1062
antibodies
cancer
GSK’s John Fleming on rethinking oncology from the ground up
Pharmaforum
Fri, 07/24/20 - 11:23 am
GSK
oncology
cancer
Lung cancer study IDs new 'epigenomic' target for diagnosis and treatment
Fierce Biotech
Fri, 07/24/20 - 09:32 am
Harvard
MIT
epigenomics
cancer
lung cancer
diagnostics
Pages
« first
‹ previous
…
20
21
22
23
24
25
26
27
28
…
next ›
last »